Engineering Intern – Winslow, Maine (Summer 2027)
Elanco
Summary
As a Summer 2027 Engineering Intern with Elanco Animal Health, you will be part of the Engineering team at our Winslow, Maine manufacturing plant, contributing to a hands-on technical project focused on improving processes, solving business challenges, and supporting operational excellence.
Job description
Your Responsibilities
- Understand the manufacturing environment and how to collaborate with different stakeholders to solve problems
- Work within cross-functional teams to build vendor relationships and new process capability implementation
- Data visualization tool creation/usage and documentation updates
What You Need to Succeed (minimum qualifications)
- Education: Currently enrolled in an Engineering major including (but not limited to) Chemical, Mechanical, Electrical, or Process
- Top Skills: Experience in Microsoft Suites and a willingness to learn
What will give you a competitive edge (preferred qualifications)
- Strong communication and interpersonal skills
- Strong organizational and time management skills
- Must be able to work exceptionally well independently and with minimal supervision
Additional Information
- Travel: 10% - to corporate facility in Indianapolis, IN for opening/closing
- Location: Winslow Manufacturing Plant, Winslow, ME
Requirements
- Currently enrolled in an Engineering major including (but not limited to) Chemical, Mechanical, Electrical, or Process
- Experience in Microsoft Suites
- Willingness to learn
- Strong communication and interpersonal skills
- Strong organizational and time management skills
- Must be able to work exceptionally well independently and with minimal supervision
Benefits
- Mentorship
- Networking events
- Housing support
- Learning resources
Company overview
Elanco Animal Health Incorporated is a global leader in the animal health pharmaceutical industry, dedicated to improving the health and well-being of both pets and farm animals worldwide. Founded in 1954 as a division of Eli Lilly and Company, Elanco became an independent public company in 2018 and has since grown to become the world's second-largest independent animal health company. With approximately 9,000 employees globally, the company operates with a clear purpose: 'making life better for animals, makes life better.' Elanco develops innovative medicines, vaccines, and health solutions that empower veterinarians, farmers, and pet owners to advance animal care. The company maintains a balanced portfolio between pet health and farm animal products, offering over 200 brands that address critical health challenges ranging from companion animal diseases to livestock productivity. Headquartered in Indianapolis, Indiana, Elanco is publicly traded on the New York Stock Exchange (NYSE: ELAN) and continues to drive innovation in animal health through strategic acquisitions and dedicated research and development efforts.